简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-11-18 11:31 Humansa Appoints Don So as Chief Executive Officer to Drive the Growth Strategy for First-in-Market Healthcare Model in Hong Kong and the Greater Bay Area
2021-11-18 10:27 Humansa Appoints Don So as Chief Executive Officer to Drive the Growth Strategy for First-in-Market Healthcare Model in Hong Kong and the Greater Bay Area
2021-11-18 10:24 Icure Acquires Drug Product Approval for World’s First Donepezil Patch for Treating Dementia of the Alzheimer Type in Korea
2021-11-18 08:55 Aimmune Therapeutics Presents New PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] Data on Immunological Outcomes of Long-Term Daily Oral Immunotherapy at the EAACI PAAM Digital Meeting
2021-11-17 13:42 Celltrion’s Monoclonal Antibody Treatment regdanvimab, Approved by the European Commission for the Treatment of COVID-19
2021-11-17 13:39 IntelliCentrics and Milestone Surgery Center Announce Using ‘Trust as a Technology’ Results in Better Patient Outcomes and Faster Revenue
2021-11-17 12:21 Theramex Enters OTC Market with Femarelle®, a Non-hormonal Option to Treat Menopause Symptoms
2021-11-17 10:00 Novel Blood Pressure Stabilization Therapy Presented at Neuroscience 2021
2021-11-16 18:27 rf IDEAS Launches Its Smallest, Most Capable Desktop Reader Yet
2021-11-16 17:50 New Study Finds That Use of Masimo SedLine® PSi and DSA May Significantly Reduce Postoperative Delirium
2021-11-16 10:12 Organon to Acquire Forendo Pharma
2021-11-16 10:04 Esper and Lenovo Collaborate on Android Device Deployment in Enterprises
2021-11-15 15:39 Clinical Study Shows ViroStop Spray Has Preventative Effect Against Covid-19
2021-11-15 14:46 Seven Healthcare Industry "High Reliability Organization Champions" Recognized by Patient Safety Movement Foundation
2021-11-12 19:58 25 Years of Making the World a Better Place for Women: Mary Kay Ash FoundationSM Marks Milestone Anniversary
2021-11-12 19:55 Celltrion Receives CHMP Positive Opinion for regdanvimab (CT-P59) as One of the First Monoclonal Antibodies Recommended as a Treatment for COVID-19 by the CHMP
2021-11-12 15:11 GrowthOps Joins the Alida Partner Network to Elevate Customer Experiences in Asia-Pacific
2021-11-12 15:04 VFMCRP receives positive CHMP opinion for Tavneos® for the treatment of ANCA-associated vasculitis
2021-11-11 20:50 Exscientia to Report Third Quarter 2021 Financial Results on November 17, 2021
2021-11-11 16:28 Alentis Therapeutics Announces Appointments of Luca Santarelli to the Board of Directors and Rafaèle Tordjman as Chairperson

Business Wire Weibo

Press Releases

Latest Releases